Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
453.27
454.71
406.33
355.59
431.45
522.61
576.02
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
453.27
454.71
406.33
355.59
431.45
522.61
576.02
Raw Material Cost
375.90
378.54
373.73
355.83
301.69
402.58
358.46
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
283.80
287.43
274.89
250.80
180.85
311.73
319.09
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
29.33
28.63
23.38
19.66
18.27
28.08
26.72
Selling and Distribution Expenses
63.48
66.70
57.40
61.49
56.50
118.97
196.06
Other Expenses
-31.31
-31.61
-29.83
-27.05
-19.91
-33.98
-34.58
Total Expenditure (Excl Depreciation)
439.38
445.25
431.13
417.32
358.19
521.55
554.52
Operating Profit (PBDIT) excl Other Income
13.899999999999999
9.5
-24.8
-61.7
73.3
1.1
21.5
Other Income
16.12
15.38
9.93
5.04
4.85
8.01
3.45
Operating Profit (PBDIT)
105.69
101.48
72.36
34.27
185.18
80.99
40.21
Interest
29.33
28.63
23.38
19.66
18.27
28.08
26.72
Exceptional Items
-3.72
-5.80
19.96
9.69
70.18
-8.62
-5.19
Gross Profit (PBDT)
77.37
76.16
32.59
-0.24
129.76
120.03
217.55
Depreciation
75.68
76.63
87.23
90.96
107.06
71.93
15.26
Profit Before Tax
-3.04
-9.59
-18.29
-66.66
130.03
-27.64
-6.96
Tax
1.73
-0.96
1.84
2.04
6.09
4.39
5.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-5.07
-9.57
-20.61
-68.81
125.72
-31.59
-13.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-5.07
-9.57
-20.61
-68.81
125.72
-31.59
-13.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.29
0.94
0.48
0.10
-1.79
-0.44
0.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-4.77
-8.63
-20.13
-68.70
123.93
-32.03
-12.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
185.85
189.33
199.77
219.58
289.37
146.79
181.25
Earnings per share (EPS)
-0.01
-0.01
-0.02
-0.08
0.14
-0.03
-0.01
Diluted Earnings per share
-0.01
-0.01
-0.02
-0.08
0.14
-0.03
-0.01
Operating Profit Margin (Excl OI)
3.06%
2.08%
-6.1%
-17.36%
16.98%
0.2%
3.73%
Gross Profit Margin
16.03%
14.74%
16.97%
6.83%
54.95%
8.47%
1.44%
PAT Margin
-1.12%
-2.1%
-5.07%
-19.35%
29.14%
-6.04%
-2.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -0.31% vs 11.91% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 44.19% vs 57.21% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 4.07% vs 37.98% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 2.45% vs 22.22% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Modern Healthcare Technology Holdings Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
453.27
172.83
280.44
162.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
453.27
172.83
280.44
162.26%
Raw Material Cost
375.90
94.48
281.42
297.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
283.80
52.24
231.56
443.26%
Power Cost
0
0
0.00
Manufacturing Expenses
29.33
3.61
25.72
712.47%
Selling and Distribution Expenses
63.48
64.13
-0.65
-1.01%
Other Expenses
-31.31
-5.59
-25.72
-460.11%
Total Expenditure (Excl Depreciation)
439.38
158.60
280.78
177.04%
Operating Profit (PBDIT) excl Other Income
13.89
14.23
-0.34
-2.39%
Other Income
16.12
14.31
1.81
12.65%
Operating Profit (PBDIT)
105.69
53.74
51.95
96.67%
Interest
29.33
3.61
25.72
712.47%
Exceptional Items
-3.72
0.00
-3.72
Gross Profit (PBDT)
77.37
78.35
-0.98
-1.25%
Depreciation
75.68
25.20
50.48
200.32%
Profit Before Tax
-3.04
24.93
-27.97
-112.19%
Tax
1.73
8.13
-6.40
-78.72%
Provisions and contingencies
0
0
0.00
Profit After Tax
-5.07
17.29
-22.36
-129.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-5.07
17.29
-22.36
-129.32%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.29
-0.50
0.79
158.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-4.77
16.79
-21.56
-128.41%
Equity Capital
0
0
0.00
Face Value
0.10
0.00
0.00
Reserves
185.85
268.42
-82.57
-30.76%
Earnings per share (EPS)
-0.01
0.01
-0.02
-200.00%
Diluted Earnings per share
-0.01
0.01
-0.02
-200.00%
Operating Profit Margin (Excl OI)
3.06%
8.23%
0.00
-5.17%
Gross Profit Margin
16.03%
29.01%
0.00
-12.98%
PAT Margin
-1.12%
10.01%
0.00
-11.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 45.33 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -0.31% vs 11.91% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -0.48 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 44.19% vs 57.21% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.96 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 4.07% vs 37.98% in Mar 2024
Annual - Interest
Interest 2.93 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 2.45% vs 22.22% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.06%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






